| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2988171 | Journal of Vascular Surgery | 2015 | 9 Pages |
Abstract
The results of the ROADSTER trial demonstrate that the use of the ENROUTE Transcarotid NPS is safe and effective at preventing stroke during CAS. The overall stroke rate of 1.4% is the lowest reported to date for any prospective, multicenter clinical trial of CAS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christopher J. MD, Michael R. DO, J. Ignacio MD, L. Nelson MD, Rasesh M. MD, Todd M. MD, Sumaira MD, Richard P. MD,